FIELD: medicine.
SUBSTANCE: there is described medical device for implantation into vessels or lumen structures in body, which stimulates positive reconstruction of blood vessels. Medical device, such as stent and synthetic transplant, is covered with pharmaceutical composition, consisting of matrix with controlled release and one or several pharmaceutical substances intended for direct delivery of medications into surrounding tissues. In addition, coating on medical device contains ligand, such as peptide, antibody or small molecule, in tended for capturing of precursor-cells on contacting with blood device surface for restoration of endothelium on stenosis site. In particular, covered with medication stents are intended for application, for instance in procedures of balloon angioplasty for prevention or inhibition of re-stenosis.
EFFECT: device represents biologically compatible system for delivery of therapeutic medications locally in safe and controlled manner.
24 cl, 57 dwg, 2 tbl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITIONS | 2004 |
|
RU2363497C2 |
COMPOUNDS POSSESSING ACIVATING ACTION ON PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SUBTYPES (PPARs), AND METHOD FOR PRODUCING AND USING ABOVE COMPOUNDS | 2011 |
|
RU2546117C2 |
STENTS WITH COATING CONTAINING N-{5-[4-(4-METHYLPIPERAZINOMETHYL)BENZOYL-AMIDO]-2-METHYLPHENYL}-4-(3-PYRIDYL)-2-PYRIMIDINAMIN | 2003 |
|
RU2341266C2 |
ELUTING STENT WITH CONTAINERS | 2010 |
|
RU2541753C2 |
ANTAGONIST-LIGAND RAR-γ OR AGONIST-LIGAND RAR-α AS INHIBITOR OF APOPTOSIS | 1996 |
|
RU2191008C2 |
METHODS FOR INDUCING T-CELLULAR TOLERANCE FOR TISSUE OR ORGAN TRANSPLA - NT | 1995 |
|
RU2169009C2 |
LIGANDS FOR G-PROTEIN CONJUGATED RECEPTOR | 2005 |
|
RU2454416C2 |
LOCAL DELIVERY OF COMBINATION OF ADENOSINE A2A RECEPTOR AGONISTS/PHOSPHODIESTERASE INHIBITOR IN VESSELS TO RELIEVE MYOCARDIAL INVOLVEMENT SEVERITY | 2011 |
|
RU2565403C2 |
NOVEL 951 COMPOUNDS: BIPHENYLOXYPROPANOIC ACID AS CRTh2 RECEPTOR MODIFIER AND INTERMEDIATE COMPOUNDS | 2008 |
|
RU2472785C2 |
NEW CANNABYHEROLE DERIVATIVES | 2015 |
|
RU2684913C2 |
Authors
Dates
2010-09-27—Published
2006-11-15—Filed